Egenix's Asset Sale

Egenix raised a round of funding on July 23, 2015. Investors include Bantam Pharmaceutical.

Egenix is a privately held, New York-based biotechnology company focused on the development of innovative cancer therapeutics. The company's therapeutic platform technology consists of small molecule …

Articles about Egenix's Asset Sale: